Application
TNNC2 Antibody (C-term) western blot analysis in K562 cell line lysates (35ug/lane).This demonstrates the TNNC2 antibody detected the TNNC2 protein (arrow).Application
TNNC2 Antibody (C-term) western blot analysis in mouse spleen tissue lysates (35ug/lane).This demonstrates the TNNC2 antibody detected the TNNC2 protein (arrow).| Product Name | TNNC2 (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | TNNC2; Troponin C, skeletal muscle |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | TNNC2 Troponin C skeletal muscle |
|---|---|
| Molecular Weight(MW) | 18122 Da |
| Function | Troponin is the central regulatory protein of striated muscle contraction. Tn consists of three components: Tn-I which is the inhibitor of actomyosin ATPase, Tn-T which contains the binding site for tropomyosin and Tn-C. The binding of calcium to Tn-C abolishes the inhibitory action of Tn on actin filaments |
| Tissue Specificity | This TNNC2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 97-126 amino acids from the C-terminal region of human TNNC2. |
| Entrez Gene | 7125 |
|---|---|
| Nucleotide Accession | NP_003270.1 |
Application
TNNC2 Antibody (C-term) western blot analysis in K562 cell line lysates (35ug/lane).This demonstrates the TNNC2 antibody detected the TNNC2 protein (arrow).
Application
TNNC2 Antibody (C-term) western blot analysis in mouse spleen tissue lysates (35ug/lane).This demonstrates the TNNC2 antibody detected the TNNC2 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
